3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Acute
2
Leukemia
2
Relapsed Pediatric Solid Tumor
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Mastocytosis, Systemic
1
Lymphoma, T-Cell, Peripheral
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Gastrointestinal Stromal Tumors
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Temozolomide
2
nimotuzumab
1
Vinorelbine
1
Valproic Acid
1
Radiotherapy
1
Everolimus
1
Erlotinib Hydrochloride
1
Drug Therapy
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Diffuse Intrinsic Pontine Glioma
×
Dasatinib
×
Clear all
NCT02233049
2018-07-23
BIOMEDE
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
Unknown
250 enrolled